180 related articles for article (PubMed ID: 19375529)
1. Proteomic diagnosis competition: design, concepts, participants and first results.
Mertens BJ
J Proteomics; 2009 Jul; 72(5):785-90. PubMed ID: 19375529
[TBL] [Abstract][Full Text] [Related]
2. Feature selection and nearest centroid classification for protein mass spectrometry.
Levner I
BMC Bioinformatics; 2005 Mar; 6():68. PubMed ID: 15788095
[TBL] [Abstract][Full Text] [Related]
3. Mass spectrometry in proteomics.
McCormack AL
Methods; 2005 Mar; 35(3):209-10. PubMed ID: 15722217
[No Abstract] [Full Text] [Related]
4. SELDI-TOF-MS proteomics of breast cancer.
Clarke CH; Buckley JA; Fung ET
Clin Chem Lab Med; 2005; 43(12):1314-20. PubMed ID: 16309366
[TBL] [Abstract][Full Text] [Related]
5. International competition on mass spectrometry proteomic diagnosis.
Mertens B
Stat Appl Genet Mol Biol; 2008; 7(2):Article1. PubMed ID: 19852745
[TBL] [Abstract][Full Text] [Related]
6. Proteomic approach to breast cancer.
Laronga C; Drake RR
Cancer Control; 2007 Oct; 14(4):360-8. PubMed ID: 17914336
[TBL] [Abstract][Full Text] [Related]
7. Multicenter matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI MSI) identifies proteomic differences in breast-cancer-associated stroma.
Dekker TJ; Balluff BD; Jones EA; Schöne CD; Schmitt M; Aubele M; Kroep JR; Smit VT; Tollenaar RA; Mesker WE; Walch A; McDonnell LA
J Proteome Res; 2014 Nov; 13(11):4730-8. PubMed ID: 24762205
[TBL] [Abstract][Full Text] [Related]
8. Differentiating proteomic biomarkers in breast cancer by laser capture microdissection and MALDI MS.
Sanders ME; Dias EC; Xu BJ; Mobley JA; Billheimer D; Roder H; Grigorieva J; Dowsett M; Arteaga CL; Caprioli RM
J Proteome Res; 2008 Apr; 7(4):1500-7. PubMed ID: 18386930
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatic methods to exploit mass spectrometric data for proteomic applications.
Chalkley RJ; Hansen KC; Baldwin MA
Methods Enzymol; 2005; 402():289-312. PubMed ID: 16401513
[TBL] [Abstract][Full Text] [Related]
10. [Application of mass spectrometry imaging in tumor diagnosis and treatment].
Mao X; Sun J; Chen J
Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):285-8. PubMed ID: 24915826
[No Abstract] [Full Text] [Related]
11. Breast cancer diagnosis from proteomic mass spectrometry data: a comparative evaluation.
Hand DJ
Stat Appl Genet Mol Biol; 2008; 7(2):Article15. PubMed ID: 19120032
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous and exact interval estimates for the contrast of two groups based on an extremely high dimensional variable: application to mass spec data.
Park Y; Downing SR; Kim D; Hahn WC; Li C; Kantoff PW; Wei LJ
Bioinformatics; 2007 Jun; 23(12):1451-8. PubMed ID: 17459967
[TBL] [Abstract][Full Text] [Related]
13. Clinical proteomics in breast cancer: a review.
Gast MC; Schellens JH; Beijnen JH
Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
[TBL] [Abstract][Full Text] [Related]
14. Global and targeted quantitative proteomics for biomarker discovery.
Veenstra TD
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):3-11. PubMed ID: 17023222
[TBL] [Abstract][Full Text] [Related]
15. Biomarker Signature Discovery from Mass Spectrometry Data.
Kong A; Gupta C; Ferrari M; Agostini M; Bedin C; Bouamrani A; Tasciotti E; Azencott R
IEEE/ACM Trans Comput Biol Bioinform; 2014; 11(4):766-72. PubMed ID: 26356346
[TBL] [Abstract][Full Text] [Related]
16. The importance of experimental design in proteomic mass spectrometry experiments: some cautionary tales.
Hu J; Coombes KR; Morris JS; Baggerly KA
Brief Funct Genomic Proteomic; 2005 Feb; 3(4):322-31. PubMed ID: 15814023
[TBL] [Abstract][Full Text] [Related]
17. Annexin A3 is a mammary marker and a potential neoplastic breast cell therapeutic target.
Zeidan B; Jackson TR; Larkin SE; Cutress RI; Coulton GR; Ashton-Key M; Murray N; Packham G; Gorgoulis V; Garbis SD; Townsend PA
Oncotarget; 2015 Aug; 6(25):21421-7. PubMed ID: 26093083
[TBL] [Abstract][Full Text] [Related]
18. The application of proteomic techniques to fungal protein identification and quantification.
Rohrbough JG; Galgiani JN; Wysocki VH
Ann N Y Acad Sci; 2007 Sep; 1111():133-46. PubMed ID: 17344531
[TBL] [Abstract][Full Text] [Related]
19. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.
Ou K; Yu K; Kesuma D; Hooi M; Huang N; Chen W; Lee SY; Goh XP; Tan LK; Liu J; Soon SY; Bin Abdul Rashid S; Putti TC; Jikuya H; Ichikawa T; Nishimura O; Salto-Tellez M; Tan P
J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472
[TBL] [Abstract][Full Text] [Related]
20. Surface-enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node-negative breast cancer tumors.
Ricolleau G; Charbonnel C; Lodé L; Loussouarn D; Joalland MP; Bogumil R; Jourdain S; Minvielle S; Campone M; Déporte-Fety R; Campion L; Jézéquel P
Proteomics; 2006 Mar; 6(6):1963-75. PubMed ID: 16470659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
